Shielding

See letter here sent to Very High Risk Patient by Catherine Calderwood, Chief Medical Officer.

Very High Risk Patients are classed as:

  1. Solid Organ Transplant Recipients
  2. People with specific Cancers
    • People with cancer who are undergoing active chemotherapy or radical radiotherapy for lung cancer
    • People with cancers of the blood or bone marrow such as leukaemia, lymphoma or myeloma who are at any stage of treatment
    • People with immunotherapy or continuing antibody treatments for cancer
    • People have other targeted cancer treatments hich can affect the immune system, such as protein kinase inhibitors or PARP inhibitors
    • People who have had bone marrow or stem cell transplants in the last 6 months, or who are still taking immunosuppression drugs
  3. People with severe respiratory conditions including al cystic fibrosis, severe asthma and severe COPD
  4. People with rare diseases and inborn errors of metabolism that significantly increase the risk of infections (such as SCID, homozygous sickle cell)
  5. People on immunosuppression therapies sufficient to significantly increase risk of infection
  6. People who are pregnant with significant heart disease, congential or acquired.